IQ EQ Fund Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-23,579
| Closed | -$1.43M | – | 318 |
|
|
2023
Q3 | $1.43M | Buy |
23,579
+21,231
| +904% | +$1.28M | 0.29% | 102 |
|
|
2023
Q2 | $239K | Hold |
2,348
| – | – | 0.05% | 222 |
|
|
2023
Q1 | $415K | Buy |
2,348
+228
| +11% | +$40.3K | 0.08% | 160 |
|
|
2022
Q4 | $820K | Buy |
2,120
+105
| +5% | +$40.6K | 0.17% | 122 |
|
|
2022
Q3 | $679K | Sell |
2,015
-1,676
| -45% | -$565K | 0.15% | 133 |
|
|
2022
Q2 | $1.21M | Buy |
3,691
+177
| +5% | +$58.2K | 0.24% | 124 |
|
|
2022
Q1 | $1.54M | Sell |
3,514
-1,346
| -28% | -$589K | 0.25% | 126 |
|
|
2021
Q4 | $2.13M | Buy |
4,860
+509
| +12% | +$223K | 0.33% | 102 |
|
|
2021
Q3 | $2.42M | Buy |
4,351
+2,298
| +112% | +$1.28M | 0.37% | 91 |
|
|
2021
Q2 | $1.06M | Buy |
2,053
+514
| +33% | +$264K | 0.16% | 152 |
|
|
2021
Q1 | $1.2M | Buy |
1,539
+1,062
| +223% | +$830K | 0.21% | 149 |
|
|
2020
Q4 | $260K | Buy |
+477
| New | +$260K | 0.06% | 208 |
|